Literature DB >> 7462232

Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content.

C J Fielding, P E Fielding.   

Abstract

Very low density lipoproteins and low density lipoproteins attain maximal cholesteryl ester contents during the incubation of human plasma and, under these conditions, both lecithin:cholesterol acyltransferase and transfer proteins are inhibited. These lipoproteins provide the major part of free cholesterol for the lecithin:cholesterol acyltransferase reaction, and are the major acceptors of cholesteryl ester generated by lecithin:cholesterol acyltransferase and transported to the lipoprotein acceptors by the transfer protein. The results obtained indicate that the concentration of acceptor limits esterification and transfer in plasma, and that in vivo these acceptors contain close to their maximal cholesteryl ester content. Human plasma end product acceptor lipoproteins have a composition similar to that of the ester-rich large low density lipoprotein characteristic of primate models of experimental atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462232

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

2.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

3.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

Authors:  H Dieplinger; P Y Schoenfeld; C J Fielding
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

4.  Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.

Authors:  Shigemasa Tani; Atsuhiko Takahashi; Ken Nagao; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2015-04-19       Impact factor: 2.037

5.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

6.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  [Phospholipids as emulsifiers in fat emulsions--effect on phospholipids in the serum lipoprotein fraction d greater than 1.063].

Authors:  S Hailer; S Kalb; G Wolfram
Journal:  Z Ernahrungswiss       Date:  1988-03

8.  Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.

Authors:  P E Fielding; C J Fielding; R J Havel; J P Kane; P Tun
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.

Authors:  F T Yen; R J Deckelbaum; C J Mann; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer.

Authors:  C J Fielding; G M Reaven; G Liu; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.